Skip to main menu Skip to main content Skip to footer
neurotech logo Accessibility Menu
Healthcare Professionals
  • About Us
    • Our Team
      • Leadership Team
      • Board of Directors
      • Medical Advisory Board
    • Careers
    • Contact Us
  • Our Product
  • Science & Technology
    • Publications
  • Clinical
  • Patients
  • News
  • Healthcare Professionals

Author: glacialcm

Home » Archives for glacialcm » Page 3

Media Contact

Monique Watson
m.smith@neurotechusa.com

Click to read Rich Small, Chief Executive Officer Joins the Executive Panel Discussion “Innovations in the Posterior Segment” at the Octane Ophthalmology Tech Forum in Newport Beach, California on June 9, 2023

June 9, 2023

Rich Small, Chief Executive Officer Joins the Executive Panel Discussion “Innovations in the Posterior Segment” at the Octane Ophthalmology Tech Forum in Newport Beach, California on June 9, 2023

 Click to read Fast Track Designation Granted for Macular Telangiectasia Type 2 (MacTel)

December 17, 2018

Fast Track Designation Granted for Macular Telangiectasia Type 2 (MacTel)

 Click to read NT-501 Granted Orphan-Drug Designation for Macular Telangiectasia Type 2 (MacTel)

July 24, 2012

NT-501 Granted Orphan-Drug Designation for Macular Telangiectasia Type 2 (MacTel)

< 1 2 3
neurotech logo
About Us Science & Technology Clinical Patients Our Product News Careers Publications
Stay Connected
Linked
,
Twitter
,
Instagram
Contact Us
Main Phone Number
Phone Icon 401-333-3880
Headquarters
Map Pin Icon
900 Highland Corporate Drive,
Suite 101
Cumberland, RI 02864
Commercial Office
Map Pin Icon
75 Second Ave, Suite 700
Needham, MA 02494
Accessibility Statement | Compliance | Privacy Policy | Consumer Health Data Privacy Notice | Supplier Code of Conduct Policy | Terms and Conditions of Use Policy
© Neurotech Pharmaceuticals, Inc. 2026
Designed by Glacial Multimedia.
⇧